CACCIATORE, Ivana
 Distribuzione geografica
Continente #
NA - Nord America 9.762
EU - Europa 6.255
AS - Asia 5.164
SA - Sud America 575
Continente sconosciuto - Info sul continente non disponibili 512
AF - Africa 83
OC - Oceania 4
Totale 22.355
Nazione #
US - Stati Uniti d'America 9.451
SG - Singapore 2.062
IT - Italia 1.520
CN - Cina 1.374
RU - Federazione Russa 1.166
IE - Irlanda 679
UA - Ucraina 556
VN - Vietnam 539
GB - Regno Unito 517
SE - Svezia 503
BR - Brasile 432
TR - Turchia 420
DE - Germania 397
FR - Francia 390
IN - India 272
FI - Finlandia 168
BD - Bangladesh 144
CA - Canada 144
HK - Hong Kong 97
PL - Polonia 61
LT - Lituania 56
MX - Messico 55
JP - Giappone 46
AR - Argentina 44
AT - Austria 39
NL - Olanda 39
BE - Belgio 37
ES - Italia 33
IQ - Iraq 30
CO - Colombia 28
KR - Corea 24
CZ - Repubblica Ceca 23
EC - Ecuador 23
IL - Israele 22
ZA - Sudafrica 21
JM - Giamaica 18
CR - Costa Rica 17
PK - Pakistan 17
GR - Grecia 16
ID - Indonesia 16
IR - Iran 16
SA - Arabia Saudita 14
TT - Trinidad e Tobago 14
CH - Svizzera 12
SV - El Salvador 12
VE - Venezuela 12
CL - Cile 11
EG - Egitto 11
HN - Honduras 11
SC - Seychelles 11
GT - Guatemala 10
MA - Marocco 10
AE - Emirati Arabi Uniti 9
JO - Giordania 9
KE - Kenya 8
MY - Malesia 8
PH - Filippine 8
CW - ???statistics.table.value.countryCode.CW??? 7
EU - Europa 7
NP - Nepal 7
PY - Paraguay 7
UY - Uruguay 7
UZ - Uzbekistan 7
DK - Danimarca 6
EE - Estonia 6
GP - Guadalupe 6
NI - Nicaragua 6
PT - Portogallo 6
TN - Tunisia 6
AZ - Azerbaigian 5
PA - Panama 5
PE - Perù 5
RO - Romania 5
DZ - Algeria 4
KZ - Kazakistan 4
NO - Norvegia 4
AU - Australia 3
CG - Congo 3
DO - Repubblica Dominicana 3
GY - Guiana 3
KW - Kuwait 3
LB - Libano 3
AG - Antigua e Barbuda 2
AL - Albania 2
BB - Barbados 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
HU - Ungheria 2
LV - Lettonia 2
NG - Nigeria 2
PR - Porto Rico 2
RS - Serbia 2
TW - Taiwan 2
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BZ - Belize 1
Totale 21.841
Città #
Singapore 1.563
San Jose 1.047
Chandler 880
Dublin 672
Jacksonville 653
Ashburn 591
Dallas 375
Beijing 336
Southend 300
Council Bluffs 295
Princeton 273
Chieti 257
Los Angeles 227
Izmir 219
New York 206
Santa Clara 194
Nanjing 193
Ho Chi Minh City 171
The Dalles 164
Dearborn 151
Ann Arbor 147
Munich 138
Wilmington 123
Hanoi 120
Pescara 116
Buffalo 109
Cambridge 98
Altamura 94
Tongling 88
Rome 86
Hong Kong 84
North Bergen 78
Boardman 73
Washington 67
Nanchang 64
Moscow 63
Columbus 62
Milan 53
Shenyang 50
Atlanta 48
Denver 48
São Paulo 44
Dong Ket 43
Chicago 42
Helsinki 42
Tokyo 42
Warsaw 42
Frankfurt am Main 41
Hefei 41
Vilnius 41
Orem 40
Tianjin 40
Kunming 39
Redondo Beach 39
Woodbridge 39
Phoenix 38
Brooklyn 36
Toronto 36
Houston 35
Montreal 35
Brussels 33
Hebei 32
Seattle 31
San Francisco 30
Chennai 28
Jinan 28
Da Nang 26
Falls Church 26
London 26
Mexico City 24
Naples 24
Nuremberg 24
Turku 24
Vienna 24
Zhengzhou 23
Boston 22
Manchester 22
Jiaxing 21
Norwalk 21
Seoul 21
Poplar 20
Brasília 19
Brno 18
Changsha 18
Grevenbroich 18
Guangzhou 18
Haiphong 18
Mount Pleasant 18
Augusta 17
Kocaeli 17
Stockholm 17
Johannesburg 16
Amsterdam 15
Ancona 15
Kimball 15
League City 15
Shanghai 15
Bologna 14
Memphis 14
Ankara 13
Totale 12.171
Nome #
A new chromogenic substrate for pantetheine hydrolase and vanin proteins 781
Toxicity assessment of hydroxyapatite nanoparticles in rat liver cell model in vitro 480
Il cofarmaco ibuprofene-glutatione quale nuovo potenziale agente anti-alzheimer 415
Chelating and antioxidant properties of l-Dopa containing tetrapeptide for the treatment of neurodegenerative diseases 228
(R)-α-Lipoyl-glycyl-L-prolyl-L-glutamyl dimethyl ester codrug as a multifunctional agent with potential neuroprotective activities 219
Development of glycine-α-methyl-proline-containing tripeptides with neuroprotective properties 215
Carvacrol reduces adipogenic differentiation by modulating autophagy and ChREBP expression 211
Preparation of boronate derivatives for the treatment of diseases and conditions associated to oxidative stress 207
Modulation of apoptotic cell death and neuroprotective effects of glutathione—L-Dopa codrug against H2O2-induced cellular toxicity 206
2,5-Diketopiperazines as neuroprotective agents 203
Advancements in Inflammatory Bowel Disease Management: From Traditional Treatments to Monoclonal Antibodies and Future Drug Delivery Systems 203
(R)-α-Lipoyl-Gly-L-Pro-L-Glu dimethyl ester as dual acting agent for the treatment of Alzheimer's disease 197
Carvacrol codrugs: A new approach in the antimicrobial plan 195
Gold nanoparticles as scaffolds for poor water soluble and difficult to vehiculate antiparkinson codrugs 188
Emerging Effects of Resveratrol Derivatives in Cells Involved in Oral Wound Healing: A Preliminary Study 187
A glutathione derivative with chelating and in vitro neuroprotective activities: synthesis, physicochemical properties, and biological evaluation. 185
Solid lipid nanoparticles loaded with lipoyl-memantine codrug: preparation and characterization 184
Synthesis of a novel cyclic prodrug of S -allyl-glutathione able to attenuate LPS-induced ROS production through the inhibition of MAPK pathways in U937 cells 182
Ameliorative Effects by Hexagonal Boron Nitride Nanoparticles against Beta Amyloid Induced Neurotoxicity 181
Memantine-derived drugs as potential antitumor agents for the treatment of glioblastoma 179
Advances in prodrug design for Parkinson's disease 178
N-Acetyl-L-Methionyl-L-Dopa-Methyl Ester as a dual acting drug that relieves L-Dopa-induced oxidative toxicity 177
Carvacrol and its derivatives as antibacterial agents 177
Synthesis and Biological Evaluation of Novel Selenyl and Sulfur-l-Dopa Derivatives as Potential Anti-Parkinson's Disease Agents 173
Synthesis of a novel TRH-related sulphonamido peptide 171
CNS delivery of L-Dopa by a new Hybrid Glutathione-Methionine peptidomimetic prodrug 171
NSAID Coniugates for the treatment of Alzheimer's Disease 170
Ibuprofen and glutathione conjugate as a potential therapeutic agent for treating Alzheimer's disease 169
A Potent (R)-alpha-bis-lipoyl Derivative Containing 8-Hydroxyquinoline Scaffold: Synthesis and Biological Evaluation of Its Neuroprotective Capabilities in SH-SY5Y Human Neuroblastoma Cells 168
GPE and GPE analogues as promising neuroprotective agents 167
Effect of MRJF4 on C6 glioma cells proliferation and migration 167
(R)-alpha-Lipoic Acid–Gly-L-Pro-L-Glu(OMe)-OMe Codrug as Multifunctional Agent for Neurodegenerative Diseases, with Antioxidant and Neuroprotective Properties 166
Carvacrol prodrugs as novel antimicrobial agents 165
Resveratrol Derivative Exhibits Marked Antiproliferative Actions, Affecting Stemness in Pancreatic Cancer Cells 164
Novel NSAID-derived drugs for the potential treatment of Alzheimer’s disease 163
Viscoelastic behaviour of hyaluronic acid formulations containing carvacrol prodrugs with antibacterial properties 163
Preparation and characterization of polymeric micelles loaded with a potential anticancer prodrug 162
Synthesis and antioxidant properties of novel memantine derivatives 162
Sintesi e valutazione dell’attività antimicrobica di nuovi carvacrolo codrugs 161
Nano-delivery systems based on carvacrol prodrugs and fibrous clays 160
Synthesis and preliminary pharmacological evaluation of 2,3,4,8,13a-hexahydro-1H-benzo(5,6)cyclohepta(1,2,3-ef)(3)benzazepine-6,7-diol derivatives as dopamine receptor ligands 154
Synthesis of Short Cationic Antimicrobial Peptidomimetics Containing Arginine Analogs 153
L-dopa co-drugs in nanostructured lipid carriers: A comparative study 152
Synthesis and evaluation of trans-2-amino-5(or 6)-chloro-6(or 5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligands 151
Biochemical properties of new synthetic carnosine analogues containing the residue of 2,3-diaminopropionic acid: the effect of N-acetylation 151
Cofarmaci L-Dopa-antiossidanti solforati quali nuovi potenziali agenti anti-Parkinson 151
Codrugs Linking l-Dopa and Sulfur-Containing Antioxidants: New Pharmacological Tools against Parkinson’s Disease 150
Synthesis and biological evaluation of novel analogues of Gly-l-Pro-l-Glu (GPE) as neuroprotective agents 150
Evaluation of 2,3,4,8,13a hexahydro-1H-Benzo[5,6]cyclohepta-6,7-dihydroxy[1,2,3-ef][3]benzazepine derivatives as dopamine receptor ligands 148
Sintesi di trans-2-ammino-5(o 6)-cloro-6(o 5)-idrossi-1-fenil-2,3-diidro-1H-indani quali precursori di derivati a potenziale affinità per i recettori della dopamina 147
New pharmacologic tools against Parkinson's disease: L-Dopa-antioxidant codrugs containing the methionine residue 147
N-(tert-butilossicarbonil)-beta,beta-ciclopentil-cisteina (acetamidometil)-metil estere per la sintesi di nuovi derivati peptidomimetici 145
synthesis and Activity of L-Dopa-Thiol antioxidant Co-drugs and New anti-PArkinson Agents with free Radical Scavenging Properties 144
Synthesis and Study of L-Dopa-Glutathione Codrugs as New Anti-Parkinson Agents with Free Radical Scavenging Properties. 143
N-(tert)-Butyloxycarbonyl-beta,beta-Cyclopentyl-Cysteine (Acetamidomethyl)-Methyl Ester for Synthesis of Novel Peptidomimetic Derivatives 143
Synthesis, characterization and evaluation of gemfibrozil-stilbene hybrid as antioxidant agent 143
From self-Assembly to healing: Engineering ultra-Small peptides into supramolecular hydrogels for controlled drug release 142
Sintesi di trans-2-ammino-1-fenil-5-fluoro-6-idrossi (e 6-fluoro-5-idrossi)-2,3-diidro-1H-indeni quali potenziali ligandi per i recettori dopaminergici 142
sintesi ed attività di due analoghi del glutatione a conformazione ristretta 142
Discovery of novel RIP derivatives by alanine scanning for the treatment of S. aureus infections. 140
Efficacy of the quorum sensing inhibitor FS10 alone and in combination with tigecycline in an animal model of staphylococcal infected wound. 140
Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases 140
Anti-Obesity and Anti-Inflammatory Effects of Novel Carvacrol Derivatives on 3T3-L1 and WJ-MSCs Cells 139
Synthesis and biological evaluation of a novel pyroglutamil-modified TRH analogue 138
Synthesis and activity of fluorescent glutathione S-conjugates as novel GST inhibitors 138
Nanoencapsulation strategies for the delivery of novel bifunctional antioxidant/σ1 selective ligands 138
Novel anti-Alzheimer phenol-lipoyl hybrids: Synthesis, physico-chemical characterization, and biological evaluation 138
Anticancer effects of novel NSAIDs derivatives on cultured human glioblastoma cells 138
Synthesis and preliminary pharmacological evaluation of trans-2-amino-5(6)-chloro-6(5)-hydroxy-1- phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligands 137
Delivery Methods of Camptothecin and Its Hydrosoluble Analogue Irinotecan for Treatment of Colorectal Cancer 137
Memantine-sulphur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer’s disease 137
Development of l-Dopa-containing diketopiperazines as blood-brain barrier shuttle 136
RNAIII Inhibiting Peptide (RIP) and derivatives as potential tools for the treatment of S. aureus biofilm infections 136
Synthesis and Biological Evaluation of Novel Cinnamic Acid-Based Antimicrobials 136
In Vitro Wound-Healing Properties of Water-Soluble Terpenoids Loaded on Halloysite Clay 135
Synthesis and evaluation of new endomorphoin analogues modified at the Pro2 residue 134
Preparation and pharmacological characterization of trans-2-amino-5(6)-fluoro-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as D2-like dopamine receptor agonists 134
Transition state isosteres of the gamma-glutamyl peptide bond hydrolysis: synthesis and characterization of the psi (CH2NH) pseudopeptide analogue of glutathione 134
Multiple lipid nanoparticles as antimicrobial drug delivery systems 133
CAPE derivatives: Multifaceted agents for chronic wound healing 132
Carvacrol prodrugs with antimicrobial activity loaded on clay nanocomposites 132
Direct- and spacer-coupled codrug strategies for the treatment of Alzheimer’s disease 131
synthesis and biological evaluation as anti-Parkinson agent of an analogue of Glutathione-L-Dopa containing methionine in place of the cysteinil residue 131
Role of Dietary Supplements in the Management of Parkinson's Disease 131
Antifungal Activity of Novel Formulations Based on Terpenoid Prodrugs against C. albicans in a Mouse Model 131
Nuovi S-coniugati del glutatione ad attività inibitoria nei confronti delle GST umane 129
Hepatic effects of yttrium oxide nanoflowers: in vitro risk evaluation 129
Histidyl-proline diketopiperazine isomers as multipotent anti-alzheimer drug candidates 129
Dimeric L-dopa derivatives as potential prodrugs. 128
Facile transformation of glutamic acid into proline residue inside a tripeptide backbone 128
Cytotoxicity and genotoxicity of iron oxide nanoparticles: An in vitro biosafety study 128
Conformationally Constrained Histidines in the Design of Peptidomimetics: Strategies for the χ-Space Control 127
New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation 127
Potent isozyme-selective inhibition of human glutathione S-transferase A1-1 by a novel glutathione S-conjugate 127
Synthesis and Characterization of Memantine-Loaded Niosomes for Enhanced Alzheimer’s Disease Targeting 127
Structure-Activity relationships of biphalin analogs and their biological evaluation on opioid receptors 126
A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential 126
Design, synthesis and evaluation of new endomorphin analogues incorporating constrained aminoacids in place of Pro2 residue 124
Neuroinflammation and endoplasmic reticulum stress are coregulated by cyclo(His-Pro) to prevent LPS neurotoxicity 124
Proline-Glutamate Chimeras in Isopeptides. Synthesis and Biological Evaluation of Conformationally Restricted Glutathione Analogues 122
Totale 16.625
Categoria #
all - tutte 85.899
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.899


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022611 0 0 0 0 88 33 36 50 103 33 70 198
2022/20232.378 177 358 155 258 212 451 114 216 281 47 54 55
2023/20241.295 97 66 72 47 63 409 273 70 20 22 25 131
2024/20253.166 161 584 519 119 42 188 111 177 255 156 354 500
2025/20267.138 544 289 572 803 639 383 1.055 381 1.280 578 357 257
2026/20272.581 525 338 355 1.044 319 0 0 0 0 0 0 0
Totale 22.355